LONDON--(EON: Enhanced Online News)--A researcher at Michigan State University has developed a point-of-care (POC) diagnostic system that can shorten the bacteria testing process from days to hours, allowing for faster and more accurate treatment of infectious diseases. POC devices such as this one, which is known as In-Dx, are making diagnosis and treatment quicker and more accessible. In Europe, they are the fastest-growing segment of laboratory diagnostics. Infiniti Research expects POC testing to play a major role in diagnosis and monitoring in the near future.
View the latest study: https://www.infinitiresearch.com/casestudy/market-intelligence-dca-poct
Bacterial infections are a serious concern, especially in hospitals. It is important to diagnose them quickly and accurately in order to treat the patient and prevent infections from spreading to other people. However, because tests to identify these infections can often take days, doctors use multiple antibiotics at once while they wait to discover the specific bacteria that needs treating. This practice leads patients to develop drug resistance.
In-Dx has been in a clinical trial for over a year, and results so far are promising. It currently has an 85% success rate, demonstrating a high sensitivity and specificity in detection. For some infections, speed can mean the difference between life and death. Sepsis patients, for example, can die within hours if not properly treated. Devices like In-Dx therefore have the potential to save millions of lives, as well as help solve the drug resistance problem by reducing the number of antibiotics used on patients.
Looking for healthcare research? Get your free quote
The medical device market is a competitive one, with new POC testing devices posing a threat both to traditional testing methods and to existing POC diagnostic processes. Any company looking to introduce new products to this market needs to be very familiar with it before taking the plunge. A global company that provides point-of-care testing solutions in the clinical chemistry field recently approached Infiniti Research to gain a better understanding of the future market space for dry chemistry analyzer (DCA) for POCT.
Infiniti’s analysts were tasked with providing the client a detailed analysis of the market size and technological advancements, realistic growth opportunities, and identifying potential factors that would influence and challenge the sales of their products across the Eastern European region.
The solutions offered by Infiniti Research comprised information on the major stakeholders of the healthcare industry in the targeted regions, including pharmaceutical companies, clinical labs, medical equipment suppliers, IT service providers, and insurance companies. The client also gained insights on the major suppliers, best practices, and which existing medical equipment suppliers are best suited to form a partnership with.
Have questions about this study? Request more information on this report
Related Healthcare Industry Studies:
About Infiniti Research
Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies.
With 13 years of experience and offices across three continents, Infiniti Research has been instrumental in providing a complete range of competitive intelligence, strategy, and research services for over 550 companies across the globe.